Biostar Pharmaceuticals, Inc. Accounts Receivable
Biostar Pharmaceuticals, Inc. had Accounts Receivable of $0 as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2017-11-20
- 2017-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2017-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2017-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $5.56M.
- 2016-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.74M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-20 |
| 2017-06-30 | $0.00 10-Q · filed 2017-11-15 |
| 2017-03-31 | $5.56M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $6.74M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $6.09M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $7.75M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $14.71M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $15.81M 10-K · filed 2017-04-13 |
| 2015-09-30 | $29.19M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $28.93M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $24.62M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $26.96M 10-K · filed 2016-04-14 |
| 2014-09-30 | $29.37M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $24.67M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $18.99M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $17.97M 10-K · filed 2015-04-15 |
| 2013-09-30 | $13.08M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $13.48M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $16.51M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $21.85M 10-K · filed 2014-03-31 |
| 2012-09-30 | $28.82M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $23.58M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $34.47M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $35.03M 10-K · filed 2013-04-15 |
| 2011-09-30 | $32.47M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $32.59M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $28.54M 10-K · filed 2012-03-27 |